The aim of this study is to

-describe the different channels through which reimbursement for the use of different health technologies is regulated

-analyse the processes and criteria in the decisions for reimbursement + the impact of those decisions on the market potential of those technologies

-analyse de characteristics of manufacturers (and technologies) who achieved reimbursement and/or succesfull market acces for their technologies.